RIV-BIM-4d
not tested on Cholinesterases
General
Type : Monoamine-oxidase-inhibitor, Multitarget, Derivative of Rivastigmine, Benzimidazole
Chemical_Nomenclature :
Canonical SMILES : CCN(C(OC1=CC=C(C=C1)CCCNC(C2=CC=C3C(=C2)N=C([N]3)C4=CC=CC=C4O)=O)=O)C
InChI : InChI=1S\/C27H28N4O4\/c1-3-31(2)27(34)35-20-13-10-18(11-14-20)7-6-16-28-26(33)19-12-15-22-23(17-19)30-25(29-22)21-8-4-5-9-24(21)32\/h4-5,8-15,17,32H,3,6-7,16H2,1-2H3,(H,28,33)(H,29,30)
InChIKey : IDMPSXNCFUCCJH-UHFFFAOYSA-N
Other name(s) :
Target
Families : RIV-BIM-4d ligand of proteins in family
ACHE
References (1)
| Title : Rivastigmine-Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases - Vicente-Zurdo_2023_Int.J.Mol.Sci_24_ |
| Author(s) : Vicente-Zurdo D , Brunetti L , Piemontese L , Guedes B , Cardoso SM , Chavarria D , Borges F , Madrid Y , Chaves S , Santos MA |
| Ref : Int J Mol Sci , 24 : , 2023 |
| Abstract : |
| PubMedSearch : Vicente-Zurdo_2023_Int.J.Mol.Sci_24_ |
| PubMedID: 37176018 |